Accel Wealth Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,841
Closed -$241K 307
2026
Q1
$241K Sell
3,841
-167
-4% -$13.4K 0.06% 238
2025
Q4
$382K Sell
4,008
-106
-3% -$10.4K 0.1% 179
2025
Q3
$402K Sell
4,114
-332
-7% -$34.4K 0.12% 172
2025
Q2
$478K Buy
4,446
+4
+0.1% +$405 0.16% 142
2025
Q1
$448K Sell
4,442
-69
-2% -$6.95K 0.16% 135
2024
Q4
$403K Sell
4,511
-12
-0.3% -$1.06K 0.15% 150
2024
Q3
$379K Sell
4,523
-342
-7% -$27K 0.14% 158
2024
Q2
$375K Buy
4,865
+1,680
+53% +$123K 0.15% 144
2024
Q1
$218K Buy
+3,185
New +$205K 0.09% 202
2023
Q2
Sell
-950
Closed -$47.5K 252
2023
Q1
$47.5K Sell
950
-200
-17% -$9.43K 0.02% 500
2022
Q4
$53.2K Hold
1,150
0.03% 351
2022
Q3
$47K Hold
1,150
0.03% 382
2022
Q2
$43K Hold
1,150
0.02% 379
2022
Q1
$52K Sell
1,150
-300
-21% -$13K 0.03% 370
2021
Q4
$62K Sell
1,450
-200
-12% -$8.4K 0.03% 339
2021
Q3
$72K Sell
1,650
-100
-6% -$4.42K 0.05% 269
2021
Q2
$75K Sell
1,750
-550
-24% -$23.1K 0.05% 271
2021
Q1
$89K Sell
2,300
-3,175
-58% -$120K 0.07% 231
2020
Q4
$197K Buy
+5,475
New +$197K 0.18% 122

Other funds holding BSX

Accel Wealth Management's BSX Position: Q2 2026 in Review

Accel Wealth Management sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 3,841 shares — an estimated $241K sold.

Accel Wealth Management first reported a position in BSX in Q4 2020 and held it in 19 quarters. The position peaked at $478K in Q2 2025. 467 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Accel Wealth Management reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Accel Wealth Management sold 3,841 Boston Scientific shares in Q2 2026, an estimated $241K.
  • Accel Wealth Management first reported a position in Boston Scientific in Q4 2020 and held it in 19 quarters.
  • Accel Wealth Management's Boston Scientific position peaked at $478K in Q2 2025.
  • 467 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Accel Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.